Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment

© 2021 by the American Academy of Ophthalmology..

Purpose: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness related to oxygen exposure in premature infants. Since oxygen monitoring protocols have reduced the incidence of treatment-requiring ROP (TR-ROP), it remains unclear whether oxygen exposure remains a relevant risk factor for incident TR-ROP and aggressive ROP (A-ROP), a severe, rapidly progressing form of ROP. The purpose of this proof-of-concept study was to use electronic health record (EHR) data to evaluate early oxygen exposure as a predictive variable for developing TR-ROP and A-ROP.

Design: Retrospective cohort study.

Participants: Two hundred forty-four infants screened for ROP at a single academic center.

Methods: For each infant, oxygen saturations and fraction of inspired oxygen (FiO2) were extracted manually from the EHR until 31 weeks postmenstrual age (PMA). Cumulative minimum, maximum, and mean oxygen saturation and FiO2 were calculated on a weekly basis. Random forest models were trained with 5-fold cross-validation using gestational age (GA) and cumulative minimum FiO2 at 30 weeks PMA to identify infants who developed TR-ROP. Secondary receiver operating characteristic (ROC) curve analysis of infants with or without A-ROP was performed without cross-validation because of small numbers.

Main Outcome Measures: For each model, cross-validation performance for incident TR-ROP was assessed using area under the ROC curve (AUC) and area under the precision-recall curve (AUPRC) scores. For A-ROP, we calculated AUC and evaluated sensitivity and specificity at a high-sensitivity operating point.

Results: Of the 244 infants included, 33 developed TR-ROP, of which 5 developed A-ROP. For incident TR-ROP, random forest models trained on GA plus cumulative minimum FiO2 (AUC = 0.93 ± 0.06; AUPRC = 0.76 ± 0.08) were not significantly better than models trained on GA alone (AUC = 0.92 ± 0.06 [P = 0.59]; AUPRC = 0.74 ± 0.12 [P = 0.32]). Models using oxygen alone showed an AUC of 0.80 ± 0.09. ROC analysis for A-ROP found an AUC of 0.92 (95% confidence interval, 0.87-0.96).

Conclusions: Oxygen exposure can be extracted from the EHR and quantified as a risk factor for incident TR-ROP and A-ROP. Extracting quantifiable clinical features from the EHR may be useful for building risk models for multiple diseases and evaluating the complex relationships among oxygen exposure, ROP, and other sequelae of prematurity.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:1

Enthalten in:

Ophthalmology science - 1(2021), 4 vom: 15. Dez., Seite 100070

Sprache:

Englisch

Beteiligte Personen:

Chen, Jimmy S [VerfasserIn]
Anderson, Jamie E [VerfasserIn]
Coyner, Aaron S [VerfasserIn]
Ostmo, Susan [VerfasserIn]
Sonmez, Kemal [VerfasserIn]
Erdogmus, Deniz [VerfasserIn]
Jordan, Brian K [VerfasserIn]
McEvoy, Cynthia T [VerfasserIn]
Dukhovny, Dmitry [VerfasserIn]
Schelonka, Robert L [VerfasserIn]
Paul Chan, R V [VerfasserIn]
Singh, Praveer [VerfasserIn]
Kalpathy-Cramer, Jayashree [VerfasserIn]
Chiang, Michael F [VerfasserIn]
Campbell, J Peter [VerfasserIn]

Links:

Volltext

Themen:

A-ROP, aggressive retinopathy of prematurity
AUC, area under the receiver operating characteristic curve
AUPRC, area under the precision-recall curve
BW, birth weight
CI, confidence interval
EHR, electronic health record
Electronic health records
FiO2, fraction of inspired oxygen
GA, gestational age
Journal Article
Machine learning
NICU, neonatal intensive care unit
Oxygen exposure
PMA, postmenstrual age
ROC, receiver operating characteristic
ROP, retinopathy of prematurity
Retinopathy of prematurity
TR-ROP, treatment-requiring retinopathy of prematurity

Anmerkungen:

Date Revised 25.10.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.xops.2021.100070

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347897886